Table 3. Tuberculosis treatment outcomes according to baseline drug resistance patterns.
Full susceptible and resistant to E, S or ES n (%) | PDR* | MDR n (%) | ||
H or HS resistance n (%) | HE or HES resistance n (%) | |||
N | 189 | 56 | 11 | 68 |
Positive outcome (success) | 161(85.2) | 45 (80.3) | 9 (81.8) | 22 (32.3) |
Cured | 154 (81.5) | 42 (75) | 6 (54.5) | 13 (19.1) |
Completed | 7 (3.7) | 3 (5.4) | 3 (27.3) | 9 (13.2) |
Negative outcome | 11 (5.8) | 3 (5.4) | 1 (9.1) | 22 (32.3) |
Failure | 4 (2.1) | 2 (3.6) | 0 | 5 (7.3) |
Death | 7 (3.7) | 1 (1.8) | 1 (9.1) | 16 (23.5) |
Defaulter | 17 (9) | 8 (14.3) | 1 (9.1) | 25 (36.7) |
Two patients were also resistant to rifampicin and rifampicin + streptomycin. Both were defaulters.
E: ethambutol; S: streptomycin; H: isoniazid; PDR: polydrug resistance; MDR: multidrug resistance.